What Does Molina Do?
Molina Healthcare was founded in 1980 in Southern California as a provider serving low-income families. Today it is a FORTUNE 500 managed care company operating across 21 US states, serving approximately 5.5 million members through Medicaid, Medicare, and the ACA Marketplace. Its Medicaid heritage gives it deep expertise in government-sponsored healthcare for the most vulnerable populations — and that specialisation is both its biggest strength and its key risk, given the program's total dependence on state and federal policy decisions.
A Notable Vote of Confidence
Michael Burry's Scion Asset Management disclosed a fresh position in Molina in Q3 2025 — 125,000 shares valued at ~$23.9M. Burry is known for contrarian, high-conviction bets. This doesn't make it a buy, but it signals that sophisticated investors see value at current levels.
BQ Score — Business Quality
Financial Performance
Revenue has grown 19% in FY2024, driven partly by the Bright Health Medicare acquisition (January 2024). However, margins have been deteriorating — medical margins have compressed from 11% in FY2024 toward 9% by Q3 2025. The full-year 2025 adjusted EPS guidance was slashed from at least $19.00 to approximately $14.00 — a ~26% cut driven primarily by rising medical costs.
| Period | Rev Growth | Medical Margin | Op Margin | FCF Margin |
|---|
| FY 2024 | +19% | 11% | 5% | 2% |
| Q1 2025 | +12% | 11% | 4% | 2% |
| Q2 2025 | +16% | 9% | 3% | — |
| Q3 2025 | +11% | 9% | 1% | — |
Risk 1 — Margin Deterioration
Q3 2025 Marketplace medical margin fell to just 4% — down from 25% in FY2024. Medicare margins also compressed from 11% to 6%. Rising utilisation and medical costs are squeezing every segment. Operating income fell 77% year-on-year in Q3 2025.
Risk 2 — Policy Exposure
Like Centene, Molina's Marketplace membership is exposed to ACA subsidy changes. Medicaid membership is subject to redetermination cycles — when states re-verify eligibility, some members lose coverage, reducing Molina's revenue without advance notice. These policy risks are ongoing and difficult to hedge.
Contract Wins — Revenue Visibility
Molina was sole plan selected by Florida AHCA for the SMMC & CHIP contract (~12,000 enrollees expected). It also won a contract with Michigan. These wins support near-term revenue visibility and demonstrate the company's ability to compete for government contracts even while managing margin pressure.
Capital Return — $1B Buyback
Molina has executed $1 billion in share repurchases so far in 2025, signalling management confidence in the long-term value of the business even as near-term earnings have been cut. At P/E of 11×, the buyback appears value-accretive if the repricing cycle normalises.
Analyst View
18 analysts cover MOH — 4 Buy, 14 Hold/Sell. Targets range from $146 to $311, averaging $185.38 against a current $181.50 — with limited consensus upside at current levels. Projected revenue growth of 10.63% in 2025 and only 3.80% in 2026. The wide target range reflects genuine disagreement about how quickly margins can recover. Current P/E of 11.18× is the best in its peer group — ranking 1st of 11 — suggesting the bad news is largely priced in.
Easy Equity Verdict
Growth is visible, execution risk is real — watch for margin stabilisation.
Molina's contract wins and acquisitions give it better revenue visibility than most peers. The $1B buyback and Burry's position suggest the stock is not expensive at current levels. But margins are very thin and deteriorating, management has already cut EPS guidance sharply once in 2025, and the Marketplace and Medicaid segments remain exposed to policy risk. The key watchpoint is whether Medicaid repricing and redetermination stabilise through 2026. If they do, Molina could outperform. If pricing is too aggressive and member losses follow, execution risk becomes the dominant story.